Key terms
About VANI
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VANI news
Mar 28
2:01am ET
Vivani Medical: A Growth-Focused Gamble with No Dividend Payouts in Sight
Mar 27
1:16pm ET
Vivani Medical’s Innovative Obesity Treatment Promises High Compliance and Market Growth: A Strong Buy Recommendation
Mar 26
8:42am ET
Vivani Medical Updates Investors with Informative Presentations
Mar 07
7:38am ET
Maxim Group Sticks to Its Buy Rating for Vivani Medical (VANI)
Mar 06
8:42am ET
Vivani Medical Expands Board, Appoints Pharma Veteran Bradbury
Mar 05
4:32pm ET
Vivani Medical Secures $15M Through Share and Warrant Sale
Feb 28
8:42am ET
Vivani Medical Touts Breakthrough in Weight Loss Drug NPM-115
Feb 28
8:42am ET
Vivani announces NPM-115 preclinical weight loss data vs. Ozempic /Wegovy
No recent press releases are available for VANI
VANI Financials
Key terms
Ad Feedback
VANI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VANI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
